Factors contributing to the hospitalization of patients with congestive heart failure

American Journal of Public Health

Volumn 87, Issue 4, 1997, Pages 643-648

  Chin, Marshall H ^a,b,d   Goldman, Lee ^a,b,c,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

EID: 0030901816     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.87.4.643     Document Type: Article

References (27)

1. Gillum RF. Epidemiology of heart failure in the United States. Am Heart J. 1993;126: 1042-1047.
2. The Advisory Board Co. Beyond Four Walls: Cost-Effective Management of Chronic Congestive Mean Failure. Washington, DC: The Advisory Board Co; 1994.
3. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure: traits among urban blacks. Arch Intern Med. 1988;148:2013-2016.
4. Goldberger JJ, Peled HB, Stroh JA, Cohen MM, Frishmann WH. Prognostic factors in acute pulmonary edema. Arch Intern Med. 1986;146:489-493.
5. Opasich C, Febo O, Riccardi G, et al. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol. 1996; 78:354-357.
6. The SOLVD Investigators. Effect of enala-pril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. NEngl J Med 1991-325293-302.
7. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. NEnglJMed. 1992;327:685-691.
8. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669-#77.
9. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the registry of Studies of Left Ventricular Dysfunction (SOLVD). SouthMedJ. 1995;88:514-523.
10. Clarke KW, Gray D, Hampton Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 1994;71:584-587.
11. Rajfer SI. Perspective of the pharmaceutical industry on the development of new drugs for heart failure. J Am Coll Cardiol. 1993;22(supplA):198A-200A.
12. McDermott MM, Feinglass J, Sy J, Gheorghiade M. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. AmJMed. 1995;99:629-635.
13. Chin MH, Goldman L. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med. 1996;156:18141820.
14. The International Classification of Diseases, 9th Revision, Clinical Modification. Washington, DC: US Health Care Financing Administration; 1991.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
16. Konstam M, Dracup K, Baker D, et al. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysmction. Clinical Practice Guideline 11. Rockville, Md: US Public Health Service; 1994. AHCPR publication 94-0612.
17. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:13761398.
18. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273: 1450-1456.
19. Clinical Quality Improvement Network Investigators. Mortality risk and patterns of practice of 4606 acute care patients with congestive heart failure: the relative importance of age, sex, and medical therapy. Arch Intern Med. 1996;156:1669-1673.
20. Sodeman WA, Burch GE. The precipitating causes of congestive heart failure. Am Heart J. 1937;22-27.
21. Flint FJ. The factor of infection in heart failure. BrMedJ. 1954;1018-1022.
22. Carder SL. Precipitating factors in congestive heart failure. J Kansas Med Soc. l%7;372-376.
23. Perlman LV, Ferguson S, Bergum K, Isenberg EL, Hammarsten JF. Precipitation of congestive heart failure: social and emotional factors. Ann Intern Med. 1971; 75:1-7.
24. Dracup K, Baker DW, Dunbar SB, et al. Management of heart failure: II. Counseling, education, and lifestyle modifications. JAMA. 1994;272:1442-1446.
25. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992;327:776-781.
26. Ashton CM, Kuykendall DH, Johnson ML, Wray NP, Wu L. The association between the quality of inpatient care and early readmission. Ann Intern Med. 1995;122: 415-421.
27. Weingarten S, Riedinger M, Conner L, Johnson B, Ellrodt AG. Reducing lengths of stay in the coronary care unit with a practice guideline for patients with congestive heart failure. Med Care. \994;32:12321243.